source
- Third Rock partner’s brain cancer diagnosis highlights personal impact of biotech drug developmentJigar Raythatha, a partner at Third Rock Ventures, was diagnosed with a rare form of brain cancer in 2023 after a routine MRI. On the same day his diagnosis was confirmed, Servier announced posit…
- Eli Lilly beats Q3 revenue forecasts, lifts full-year outlookEli Lilly reported third-quarter revenue of $24.4 billion, roughly $2 billion above analysts' expectations. The outperformance underscores the company's strong position, driven in part by its GLP-…